Cargando…
Corrigendum: Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients
Autores principales: | Chen, Ping, Song, Haolin, Xu, Wei, Guo, Jin, Wang, Jianfei, Zhou, Juhong, Kang, Xiang, Jin, Chaolei, Cai, Yubo, Feng, Zixuan, Gao, Hainv, Lu, Fengmin, Li, Lanjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154681/ https://www.ncbi.nlm.nih.gov/pubmed/37152060 http://dx.doi.org/10.3389/fonc.2023.1170066 |
Ejemplares similares
-
Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients
por: Chen, Ping, et al.
Publicado: (2022) -
Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients
por: Liu, Miaoxia, et al.
Publicado: (2020) -
Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score
por: Truong, Thai Ngoc, et al.
Publicado: (2023) -
ASAP Score versus GALAD Score for detection of hepatitis C-related hepatocellular carcinoma: A multicenter case-control analysis
por: Liu, Si-Yu, et al.
Publicado: (2022) -
GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study
por: Villa, Erica, et al.
Publicado: (2023)